首页> 外国专利> METHOD FOR TREATING CARDIOVASCULAR DISEASE THROUGH ADJUNCTIVE PHOTODYNAMIC THERAPY.

METHOD FOR TREATING CARDIOVASCULAR DISEASE THROUGH ADJUNCTIVE PHOTODYNAMIC THERAPY.

机译:通过辅助光动力疗法治疗心血管疾病的方法。

摘要

Photodynamic Therapy (PDT) is used as an adjunctive or stand alone procedure for the treatment of cardiovascular disease. When used as an adjunctive therapy to Percutaneous Transluminal Coronary Angioplasty, laser angioplasty, atherectomy, stenting, or any other interventional or surgical procedure, it has been found that the treatment timing is critical to the success of the combined therapies. A photosensitizer is administered prior to the surgical or interventional procedure and then readministered after the procedure to maintain the photosensitizer concentration level in the atheromatous plaque (8) and smooth muscle cells (2) in the vicinity of the lesion for a period of about 5-18 days, the period in which cell proliferation can occur. The photosensitizer inhibits smooth muscle cell proliferation and, thus, minimizes or eliminates the possibility of re-stenosis. The photosensitizer is then illuminated at the end of this period, thereby lysing the atheromatous plaque and smooth muscles. The photosensitizer inhibits atheromatic smooth muscle cell proliferation.
机译:光动力疗法(PDT)被用作辅助或独立程序,用于治疗心血管疾病。当用作经皮腔内冠状动脉血管成形术,激光血管成形术,旋切术,支架置入术或任何其他介入或外科手术方法的辅助治疗时,已经发现治疗时机对于联合疗法的成功至关重要。在外科手术或介入手术之前先施用光敏剂,然后在手术后重新施用光敏剂,以使病变附近的动脉粥样斑块(8)和平滑肌细胞(2)中的光敏剂浓度保持约5倍的时间18天,可以发生细胞增殖的时期。光敏剂可抑制平滑肌细胞增殖,因此可最大程度地减少或消除再狭窄的可能性。然后在该阶段结束时对光敏剂进行照明,从而裂解动脉粥样斑块和平滑肌。光敏剂抑制动脉粥样硬化平滑肌细胞增殖。

著录项

  • 公开/公告号EP0656795A4

    专利类型

  • 公开/公告日1995-09-20

    原文格式PDF

  • 申请/专利权人 PDT CARDIOVASCULAR INC.;

    申请/专利号EP19930919818

  • 发明设计人 NARCISO HUGH L. JR.;

    申请日1993-07-12

  • 分类号A61N1/30;

  • 国家 EP

  • 入库时间 2022-08-22 04:12:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号